Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Emergent BioSolutions Inc reaffirms FY 2014 revenue guidance; gives Q1 2014 revenue guidance in line with analysts' estimates


Thursday, 6 Mar 2014 04:01pm EST 

Emergent BioSolutions Inc:Reaffirms FY 2014 forecast of total revenues of $415 to $445 million.Expects FY 2014 GAAP net income of $30 to $40 million.Expects Q1 2014 total revenues of $45 to $55 million.FY 2014 revenue of $431 million - Thomson Reuters I/B/E/S.Q1 2014 revenue of $48 million - Thomson Reuters I/B/E/S. 

Related Company News

Company Quote

21.8
-0.4 -1.80%
19 Sep 2014